Mark D Denton

Summary

Affiliation: Institute for BioScience
Country: USA

Publications

  1. ncbi Heparin-induced skin necrosis in a patient with end-stage renal failure and functional protein S deficiency
    M D Denton
    Renal Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02116, USA
    Am J Nephrol 21:289-93. 2001
  2. ncbi Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis
    Mark D Denton
    Renal Division, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Kidney Int 61:2201-9. 2002
  3. ncbi Membranous lupus nephritis in a renal allograft: response to mycophenolate mofetil therapy
    M D Denton
    Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Am J Transplant 1:288-92. 2001
  4. ncbi Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation
    John P Forman
    Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
    Am J Transplant 4:1786-91. 2004
  5. ncbi TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy
    Mark D Denton
    Division of Nephrology, Department of Medicine, Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA
    Transplantation 78:1218-21. 2004
  6. ncbi Assessment by flow cytometry of intracellular cytokine production in the peripheral blood cells of renal transplant recipients
    Colm C Magee
    Laboratory of Immunogenetics and Transplantation, Renal Division, Brigham and Women s Hospital, Boston, MA 02115, USA
    Clin Transplant 18:395-401. 2004
  7. ncbi DNA microarrays: applicability to renal physiology and disease
    Mark D Denton
    Laboratory of Immunogenetics and Transplantation, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Nephrol 15:S184-91. 2002
  8. ncbi Posttransplant hemolytic uremic syndrome
    Colm C Magee
    Kidney Int 63:1958-9. 2003

Detail Information

Publications8

  1. ncbi Heparin-induced skin necrosis in a patient with end-stage renal failure and functional protein S deficiency
    M D Denton
    Renal Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02116, USA
    Am J Nephrol 21:289-93. 2001
    ..We suggest that HIT antibodies should be requested in all dialysis patients presenting with skin ulceration...
  2. ncbi Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis
    Mark D Denton
    Renal Division, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Kidney Int 61:2201-9. 2002
    ..However, the prevalence of these conditions in patients undergoing transplantation, and the clinical characteristics associated with their occurrence are unclear...
  3. ncbi Membranous lupus nephritis in a renal allograft: response to mycophenolate mofetil therapy
    M D Denton
    Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Am J Transplant 1:288-92. 2001
    ..This is the first report of successful treatment of membranous lupus nephritis in an allograft using MMF. We review all cases of transplant-associated membranous lupus nephritis in the English literature...
  4. ncbi Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation
    John P Forman
    Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
    Am J Transplant 4:1786-91. 2004
    ..A positive ACA titer prior to kidney transplantation was not associated with inferior renal outcomes after transplantation, although more research is required to address the prognostic significance of very high ACA titers...
  5. ncbi TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy
    Mark D Denton
    Division of Nephrology, Department of Medicine, Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA
    Transplantation 78:1218-21. 2004
    ..08+/-0.11). Therefore, TNP-470 interrupts the progression of CAV when given late but does not prevent its development when given immediately posttransplantation...
  6. ncbi Assessment by flow cytometry of intracellular cytokine production in the peripheral blood cells of renal transplant recipients
    Colm C Magee
    Laboratory of Immunogenetics and Transplantation, Renal Division, Brigham and Women s Hospital, Boston, MA 02115, USA
    Clin Transplant 18:395-401. 2004
    ..We hypothesized that patients with CAN would manifest different patterns of cytokine production (compared with non-CAN controls), detectable in peripheral blood mononuclear cells (PBMCs)...
  7. ncbi DNA microarrays: applicability to renal physiology and disease
    Mark D Denton
    Laboratory of Immunogenetics and Transplantation, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Nephrol 15:S184-91. 2002
    ..Ultimately, microarray technology may be used widely in the clinical setting as fingerprinting of cells, tissue, and disease states, though more targeted strategies using a limited repertoire of genes may be most valuable...
  8. ncbi Posttransplant hemolytic uremic syndrome
    Colm C Magee
    Kidney Int 63:1958-9. 2003